https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-30 / Radiat Oncol J 2016 Mar;34(1):34-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-30 / Radiat Oncol J 2016 Mar;34(1):34-442016-03-30 00:00:002019-02-15 08:39:27Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-26 / Semin. Cancer Biol. 2016 06;37-38:96-105
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-26 / Semin. Cancer Biol. 2016 06;37-38:96-1052016-03-26 00:00:002019-02-15 09:18:09Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-24 / Thorac Cancer 2016 Jul;7(4):422-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-24 / Thorac Cancer 2016 Jul;7(4):422-72016-03-24 00:00:002019-02-15 09:18:22Pilot study of radiofrequency hyperthermia in combination with gefitinib in gefitinib-effective patients with advanced NSCLC
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2016-03-12 13:53:392019-02-12 13:54:41Expertenbericht von Prof. Dr. Schirrmacher, Wiener klinisches Magazin
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-07 / Tumour Biol. 2016 Aug;37(8):11267-78
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-07 / Tumour Biol. 2016 Aug;37(8):11267-782016-03-07 00:00:002019-02-15 08:47:52Antigen-specific T cell response from dendritic cell vaccination using side population cell-associated antigens targets hepatocellular carcinoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-04 / Cancer Sci. 2016 Apr;107(4):514-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-04 / Cancer Sci. 2016 Apr;107(4):514-202016-03-04 00:00:002016-03-04 00:00:00Cetuximab delivery and antitumor effects are enhanced by mild hyperthermia in a xenograft mouse model of pancreatic cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-02 / Sci Transl Med 2016 Mar;8(328):328ra27
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-02 / Sci Transl Med 2016 Mar;8(328):328ra272016-03-02 00:00:002022-09-29 14:06:28Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-01 / J. Acquir. Immune Defic. Syndr. 2016 Mar;71(3):246-53
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-01 / J. Acquir. Immune Defic. Syndr. 2016 Mar;71(3):246-532016-03-01 00:00:002019-02-15 08:48:03Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1 Gag and Nef: Results of a Randomized, Placebo-Controlled Clinical Trial
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-01 / Oman Med J 2016 Mar;31(2):89-97
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-01 / Oman Med J 2016 Mar;31(2):89-972016-03-01 00:00:002019-02-15 09:18:11Hyperthermia: How Can It Be Used?